Form 8 (DD) - Futura Medical
Futura Medical PLC has amended its Form 8 (DD) disclosure, originally released on September 29, 2026, to include previously blank sections. Executive Director Kenneth James has disclosed his interests and dealings in Futura Medical PLC ordinary shares, owning 3,299,501 shares representing 0.22% of the class. He also holds various share options and awards under different LTIP and Tranche plans, with exercise prices ranging from 0.2p to 45p and expiry dates extending to 2034. Notably, Mr. James subscribed for 2,500,000 ordinary shares at 0.2p each as part of a recent Conditional Placing.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Amendments were made to sections 2(b) and 3(d). The tables were previously blank but have now been filled with the correct information.
The full amended text is shown below.
FORM 8 (DD)
Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”)
KEY INFORMATION
| (a) Full name of discloser: | Kenneth James | ||
| (d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) | Executive Director | ||
| (e) Date dealing undertaken: | 25 September 2026 | ||
| 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE | |||
| Class of relevant security: | Ordinary shares of 0.2p each | ||
| Interests | Short positions | ||
| Number | % | Number | % |
| (1) Relevant securities owned and/or controlled: | 3,299,501 | 0.22 | |
- Cash-settled derivatives:
- Stock-settled derivatives (including options) and agreements to purchase/sell:
| TOTAL: | 3,299,501 | 0.22 |
All interests and all short positions should be disclosed.
- Rights to subscribe for new securities (including directors’ and other employee options)
| Class of relevant security in relation to which subscription right exists: | Ordinary shares of 0.2p each |
| Details, including nature of the rights concerned and relevant percentages: | Share plan No of ordinary shares under options / awards Date of award Exercise price (per share) Vesting date Expiry date 26 LTIP 11,622,413 15 January 2026 0.2p 15 January 2027 15 July 2027 LTIP 1 509,225 7 December 22 0.2p 10 January 23 6 December 32 LTIP 2 1,366,728 10 October 23 0.2p 10 October 23 30 October 23 Tranche 16 200,000 17 September 19 31p 1 October 21 30 September 26 Tranche 17 240,000 21 September 20 15.5p 1 October 22 30 September 27 Tranche 18 264,000 5 October 21 37.90p 1 October 23 30 September 28 Tranche 20 132,000 14 September 22 45p 1 October 25 30 September 30 Tranche 21 264,000 6 April 23 43.60p 1 April 26 31 March 33 Tranche 22 280,000 19 April 24 35.5p 1 April 27 31 March 34 |
DEALINGS BY THE PERSON MAKING THE DISCLOSURE
The currency of all prices and other monetary amounts should be stated.
Purchases and sales
| Class of relevant security | Purchase/sale | Number of securities | Price per unit |
- Cash-settled derivative transactions
- Stock-settled derivative transactions (including options)
- Writing, selling, purchasing or varying
- Exercise
- Other dealings (including subscribing for new securities)
| Ordinary shares of 0.2p each | Subscription of 2,500,000 Ordinary Shares | Subscribed for as part of the recent Conditional Placing | 0.2p |
- OTHER INFORMATION
- Indemnity and other dealing arrangements
- Agreements, arrangements or understandings relating to options or derivatives
- Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 29 September 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.